Who developed the PROactive instruments?

The project and consortium

The PROactive project aimed to develop, validate and use new patient reported outcomes (PROs) to investigate dimensions of physical activity that are judged as being essential by people  living with COPD.

To protect the integrity of the PROactive instruments, the consortium holds all copyrights related to these instruments.

Consortium partners

The specific consortium partners that participated in the development of the PROactive instruments are listed below, together with their roles.

Institute Role Contact
Academic Partners
KU Leuven, Department of Rehabilitation Sciences Academic lead Thierry Troosters
The University of Edinburgh Partner Roberto Rabinovich, currently at University of Edinburgh

Thorax - Research Center of Intensive & Emergency Thoracic Medicine   Partner Ioannis Vogiatzis, currently at Northumbria University
Royal Brompton &  Harefield Nhs Foundation Trust Partner Nick Hopkinson
ISGlobal WP Lead Judith Garcia Aymerich
Universitaet Zuerich WP Lead Milo Puhan
Academisch Ziekenhuis Groningen / University Medical Center Groningen Partner Thijs van der molen
Astma Fonds Longstichting WP lead https://www.longfonds.nl/
British Lung Foundation partner https://www.asthmaandlung.org.uk/
Choice Pharma WP lead -
European Respiratory Society Partner www.ersnet.org
EFPIA Partners
Chiesi https://www.chiesi.com/en/
Astra Zeneca https://www.astrazeneca.com/
Almirall https://www.almirall.es/
GSK https://www.gsk.com/en-gb/
Boehringer Ingelheim https://www.boehringer-ingelheim.com/products
Novartis https://www.novartis.com/
Pfizer https://www.pfizer.com/
Scroll to Top